WindMIL Therapeutics

A platform for cell-based immuno-oncology therapy

United States · Founded 2016 · $32.5M raised

Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$32.5M
Last Round
$32.5M Series BJun 2018
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

WindMIL is a clinical-stage biotechnology company developing a new class of cell therapy. Founders Ivan Borrello, MD, and Kimberly Noonan, PhD, from Johns Hopkins University (JHU) have shown that T cells capable of recognizing and killing tumor cells lie dormant in the bone marrow of cancer patients. These T cells, known as marrow-infiltrating lymphocytes (MILs), can be extracted from a patient via a routine marrow draw, activated and expanded utilizing a proprietary process, and given back to the patient as an effective and durable therapy. WindMIL has exclusively licensed from JHU the patents and know-how enabling MILs therapy.

Summary

WindMIL Therapeutics is a Biotech company based in United States, founded in 2016. It has raised $32.5M in total across 1 round, most recently a $32.5M Series B round in Jun 2018. Investors include Qiming Venture Partners USA, Medivate Partners and Domain Associates.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2018
$32.5M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

WindMIL Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/windmil-therapeutics"><img src="https://indexed.vc/api/badge/company/windmil-therapeutics" alt="WindMIL Therapeutics on Indexed.vc" width="260" height="76" /></a>